Clinical Trial Update: Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating exemestane with or without bicalutamide in patients with stage IV prostate cancer has completed, reporting results from the combinati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Aromasin (exemestane)
• Casodex (bicalutamide)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED